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Abstract
Studies have shown that increase in health care expenditure is related to the income level
and economic growth of a country. But a theoretically optimal level of health expense and an
optimal growth rate are rarely investigated. This paper assumes that health expenditure is a
gross investment in human capital and follows the usual characteristics of investment in the
Solow growth model. Based on Solow, a theoretical model is developed to discuss the role of
health capital in economic growth. The model shows that convergence is present between
poorer and wealthier countries when both physical and health capitals are considered. In the
empirical analyses, this paper ﬁrst estimates the optimal steady state product level based on the
method of Mankiw, Romer and Weil (1992). Secondly, the optimal steady state health
expenditure amounts are projected assuming that the steady state situation automatically
achieves the Golden Rule consumption maximization result driven by the free market force.
The results show that most of the studied 15 OECD countries have excessive health expendi-
ture for approximately the past two decades. Some of the countries show a decreasing pattern
of overspending and ﬁnally reach the optimal level. But a few of them do not show a format
of cost containment for controlling health expenditure.
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The long-term increase of healthcare expenditure raises a great concern about the
allocation of public resources. In many countries, accurately projecting the trend of healthcare
expenditure growth and ﬁnding an optimal expenditure level have become critical tasks.
Extensive literature has already discussed the means of cost containment.
1 Studies have also
shown that healthcare expenditure is closely related to a country’s GDP level.
2 As income
increases, health expenditure is no longer just the issue of life and death, but is meant to
improve quality of living. Even though there is no unanimous conclusion in the literature,
when analyzed on the basis of an aggregate demand function, health services in most of the
developed countries are observed to be luxury goods
3 for which spending increases faster than
the growth of income.
4 For this reason, it could be imprudent to conclude that health
spending is soaring beyond control merely on the basis of the number ﬁgure of healthcare
expenditure or the ratio of healthcare expenditure to GDP. Since the income level is in general
increasing across countries over time, healthcare expenditure has to follow an increasing
pattern across countries as well. What really matters is actually whether it increases within a
reasonable range. Thus, this paper investigates whether countries really overspend and to what
extent they overspend in healthcare.
In order to understand and predict health expenditure growth, this paper builds a
theoretical growth model that explains the importance of health expenditure to human capital
followed by a set of projection models that incorporate the factors of GDP growth and
spending on national healthcare, which is considered as an investment in human capital. A
hypothetical steady-state healthcare expenditure is projected to be the base case of the optimal
expenditure level for each county at di#erent time periods. This base is then compared with the
actual expenditure level. In reality, a steady state does not exist since technologies, environ-
mental conditions, and policies of each country are constantly changing. But in the very short
run, both the physical and human capital growths are assumed to be ﬁxed. The hypothetical
steady state condition for each period in each country can be simulated given the growth
conditions as static. This paper thus projects the health expenditure level around its “pseudo”
steady state. Comparison between the projected level and the actual level will give government
authorities better understanding of the appropriateness of their health policies. The empirical
analyses also provide information on the determinants and the structure of healthcare
expenditure. By applying the projection models provided in this study, a government authority
may have a clear and reliable guide to decision-making for future healthcare and other social
welfare policies.
The result of the study shows that for most of the studied OECD countries, the health
1 See, for example Feldstein (1973), Scitovsky and Snyder (1972), Beck and Horne (1980) Sche%er (1984),
Greene and Bunselman (1986), and Gerdtham et at. (1992).
2 See, for example, Whynes (1992), McCoskey & Selden (1998), Hansen & King (1996, 1998), Newhouse
(1977, 1987), Parkin et al.(1987), Govindaraj et al. (1997), Jayasinghe et al. (1998), Van der Gaag & Barham
(1998), Cowan et al. (1996), King (1996), Burner & Waldo (1992; 1995).
3 For more discussion of whether health is a luxury or necessity good, please see Clemente, Marcuello,
Montan ˜e ´ s and Pueyo (2004), Getzen (2000).
4 See, for example, Newhouse (1977), Leu (1986), Gerdtham et al. (1992).
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actual and projected values with the growth rate slower for the former one than the latter one.
When healthcare expenditure is measured in terms of the share of GDP, the growth pattern is
strong for the projected optimal value (with the exceptions of Spain and Greece) but the actual
spending ratio is quite constant for almost all countries. In both measures, the actual values are
consistently above the projected optimal value, indicating that the economy as a whole
overspends in healthcare for almost all countries. The gaps between the actual and projected
values present a decreasing pattern for most of the countries, though. Some even overlap
gradually together, which means that the cost containment tasks for those countries have been
successful.
The remainder of the paper is organized as follows. In the next section, a growth model
with health as human capital is developed. Then the policy implication from the theoretical
part is introduced in Section 3. Section 4 presents the empirical results. Finally, Section 5
provides concluding remarks.
II. The Model
Mushkin (1962), Becker (1964), and Fuchs (1966) pointed out that health capital is one
component of the stock of human capital. Thus, in the modern growth model, it enters into the
production function of an economy:
5
Y(t)F(K(t), H(t), L(t), t)( 1 )
where Y(t) is the ﬂow of output produced at time t, K is the physical capital, H is the health
capital, and Li s labor. The production function depends on time, t, to reﬂect the e#ects of
technological progress. For simplicity, we assume a one-sector production technology in which
output is a homogeneous good that can be consumed, C(t), invested in K, Ik(t), to maintain
or create new units of physical capital, K(t), or invested in H, Ih(t), to maintain or create
better health capital, H(t). In a closed economy, output equals income, and the amount
invested equals the amount saved. Let sk and sh be the fraction of output that is saved (saving
rate) for physical capital and health capital, respectively. Also assume that dk and dh are the
corresponding depreciation rates. The next increase in the stock of physical capital and the
health capital at a point in time equals gross investment less depreciation:

KskF(K, H, L, t)dkK

HshF(K, H, L, t)dhH
(2)
where  denotes di#erentiation with respect to time, and 0sk sh1. To use the per e#ective






5 Assuming the production function is neoclassical, meaning the following three properties are satisﬁed: First, F
(.) exhibits positive and diminishing marginal products with respect to each input, second, F(.) exhibits constant
returns to scale, and third, the Inada conditions.
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equal to zero, meaning that the per e#ective unit of labor variables—k, h, y, and c—do not
grow in the steady state, and the levels of variables—K, H, Y, and C—grow in the steady state
at the rate of the population growth, n.
Transitional Dynamics
To see the e#ect of capital accumulation over time, the growth rates of these two types of







In the graphic presentation, the ﬁrst term in the right side of the equation 4.1 (4.2) shows, for
a given level of capital (health) stock, a downward-sloping curve that asymptotes to inﬁnity as
k(h) is zero and approaches zero as k(h) moves towards inﬁnity. The second term exhibits a
horizontal line. Thus the vertical distance between the curve and the line equals the growth
rate of physical capital (health stock) per person. At the steady state, the growth rate of k(h)
is zero implying that the crossing point corresponds to the steady state, which in our model
exists and is unique.
6 As a result, for an economy with more abundant capital, the growth rate
of the corresponding capital decreases. It approaches zero in the steady state and turns









For the per e#ective unit of labor output of the economy along the transition, the growth


















where ifi(.) is the income per person earned by owners of capital i, ik or h. Thus ifi(.)/
f(.) is the share of this income in total income per person, sh(i). Substituting equation (4.1)
and (4.2) into the above equation, one obtains
gyskfk(k, h)(ngdk)sh(k)shfh(k, h)(ngdh)sh(h)( 7 )
6 Since ndk0a n dskf(.)/k falls monotonically from inﬁnity to zero, the curve and the line intersect only
once.
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We then suppose that the cross e#ect of the two capital fij is small enough and negligible, and
that the growth rate of capital i is nonnegative, which is true for almost all observable data for
the OECD countries. Then the impact of i on gy is negative, meaning that as capitals
accumulate, the growth of output level slows down.
7
The Golden Rule of Capital Accumulation
For a given production function and given values of n, g, and d, there is a unique
steady-state value k* for each value of the saving rates sk, sh. The steady-state level of per
e#ective unit of labor consumption is c*f[k*(s), h*(s)](ngd)[k*(s)h*(s)]. The










Since dk*/dsk0 and dh*/dsh0, the terms in brackets must equal zero. We denote that k and
h satisfy the above condition as kgold and hgold for the maximum of c*. The corresponding saving
rate can be denoted as skgold and shgold, and the associated level of steady-state per e#ective unit
of labor consumption is given by
cgoldf(kgold, hgold)(ngd) kgold(ngd) hgold. (10)
The above equation implies that saving rates higher than skgold and shgold would be ine$cient
because higher quantities of per e#ective unit of labor consumption could be obtained at all
points in time by reducing the saving rates. However, if the saving rates fall lower than skgold
and shgold then the steady-state amount of per e#ective unit of labor consumption can be
increased by raising the saving rates. This rise in the saving rates would reduce current
consumption during part of the transition period. The optimal saving rates depend on how
households weigh today’s consumption against the path of future consumption. Thus, the
optimal investment in health capital and physical capital is determined by this Golden Rule.
III. Policy Implication and Tendency of Convergence
The above theoretical model explains the phenomena that in poorer countries where
physical capital and health stock are low, we are more likely to observe faster economic growth
7 If gi0, then the sign of (gy/(i is ambiguous for a general form of the production function. However, when
the economy is close to its steady state, then the magnitude of gi will be small and (gy/(i0 will hold even if ii*.
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by the saving rates of the corresponding capital and the output level, f(k, h). For wealthier
countries, the steady state capital stock is larger; health stock and quality of life in turn are
valued more heavily than in the poorer countries. If the government introduces a new policy
that raises the saving rate of the economy, then the steady-state per capital stock will increase
and the current growth rate of capital will also temporarily increase. As k or h increases, the
economy moves towards the new steady state while the growth rates of capital stocks fall and
approach zero.
8 Each country at a di#erent time period has a di#erent income level. The
investments in k and h for each country at di#erent times with di#erent income levels result in
di#erent rates of economic growth. From the previous section, we expect a negative relation-
ship between investment and the rate of economic growth. Hence, for wealthier countries we
expect the optimal investment level to be higher than in poorer countries. If a country is
continuously growing, then its optimal investment level also needs to be continuously increas-
ing.
A permanent improvement in the level of technology has similar, temporary e#ects on the per
e#ective unit of labor growth rates. An upward shift in the production function means an
upward shift in the sif(k, h) curve. As a result, a temporary rise in the growth rate of the
corresponding per e#ective unit of labor capital stock is observed. In the long run, the
permanent improvement in technology generates higher levels of k, h, and y, but the growth
rates are all gradually decrease toward zero as the economy approaches steady state.
IV. Empirics
In order to investigate the optimal rate of health investment of an economy, this paper
uses healthcare expenditure as the proxy in evaluation. The optimal rate exists when the
economy grows toward the consumption-maximization steady state, or the Golden Rule
status. As mentioned earlier, steady state may not exist in reality due to constantly changing
technology, cultural shifts, political movements, and change in preference in the countries.
However, a hypothetical steady state is projected assuming that shift factors freeze at a
snapshot in the time span, which is made possible by employing a panel regression model with
ﬁxed country and ﬁxed time e#ects, so that only investments in physical and human capital
stock are changeable to lead the economy towards the steady state. Much of the previous
literature emphasizes the cointegration nature of health expenditure and national income level
(Gerdtham, Lothgren, 2000, and Clemete, 2004). This paper, however, uses a di#erent
approach since healthcare expenditure is determined by many other variables, such as health
status of a country, environmental factors, population growth, and economic growth, that are
stationary and not cointegrated with healthcare expenditure. In addition, since the main issue
of this paper is to discuss the steady-state outcome, a ﬁxed-e#ect regression approach adjusted
by autoregressive command is suitable. In addition, since this paper primarily focuses on
investment in health capital, when projecting the steady state optimal investment amount,
further restriction is imposed by assuming that growth rates for all variables are zero. To
8 The e#ect can be shown by di#erentiating equation (6.1) and (6.2) with respect to corresponding capitals.
The result shows that both (gk/(k and (gh/(h exhibit negative values.
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trend of the regression function. Thus, the empirical parts are twofold. First, a steady state
output level is estimated for each country in each period of time. This steady state is assumed
to be in the optimal Golden Rule status supposing that all countries automatically maximize
their utility through market forces. Second, a two-stage least square method is applied to
estimate the health expenditure equation, assuming growth rate of health investment is
endogenous since it is subject to the economies’ social and political conditions. By so doing, the
hypothetical optimal steady state health expenditure amount can be predicted when the growth
rates of variables are zero and when the level of output is at the imputed steady-state output
level.
1. The Empirics of Steady State
The ﬁrst part of the empirical analyses is to predict the optimal steady-state output level.
We adopt from the seminal paper of Mankiw, Romer, and Weil (1992) and assume that
depreciation rates for physical and human capitals are the same. From equations (4.1) and











where y* is the steady state output level per working labor, A(0) is the initial technology, and
a and b are the coe$cients for physical and human capitals, respectively, from the production
function. In our regression for steady state y*, other than education, which Mankiw, Romer,
and Weil include, health stock is also a major concern. Thus, we include both education and
health variables in the empirical model. Data of 15 OECD countries are used for the time span
from 1980 to 1998.
10 We employ the data of real GDP at the constant 1995 price level as y,
the ratio of total capital to GDP as sk,, the ratio of education expenditure for primary and
secondary schools to GDP as sedu, the ratio of health expenditure to GDP as shealth,t h e
three-year moving average
11 of population growth rate as n, and assume gd to be 0.05 as
suggested by Mankiw, Romer, and Weil (1992). After running a panel ﬁxed-e#ect regression
method with country-speciﬁc and time-speciﬁc e#ects under control, we obtain (t statistics are
in parentheses):




ln(y*)-23.7610.165 ln(sk)0.053 ln(sedu)0.132 ln(shealth)0.191 ln(ngd)
(13.07) (2.04) (3.48) (-2.09)
R
20.943





10 The data sources include OECD Health Data 2000 and OECD Main Economic Indicators, Historical Statis-
tics, 1960-1997. But the data before 1979 have serious missing data problems.
11 The moving average of population growth can eliminate year-speciﬁc shocks for the birth spur.
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di#erent in terms of the coe$cients. Since the health variable —l n(Shealth) has signiﬁcance in
the second formula, the ﬁrst one clearly has an omitted variable problem. When the omitted
variable has positive correlation with the existing variables, the existing ones will be overesti-
mated, which is what we see for the above ﬁrst regression equation. When we compare the
results of the second formula to some other literature, we ﬁnd high similarity.
12 Therefore, for
the following estimate the second equation is used.
2. The Estimate for Health Expenditure
A range of studies, including Culyer (1990), Gerdtham et al. (1992), Hitiris and Posnett
(1992), Hitiris (1997), Zewifel et al. (1999), Richardson and Roberstson (1999), Moise and
Jacobzone (2003) and Jo ¨n sson and Eckerlund (2003), have been trying to discuss the
determinants of health expenditure across countries. Their regression attempts to control for
a variety of both ‘background’ and ‘institutional’ inﬂuences, including income, demography
and ﬁscal constraints. Starting from these premises, the empirical literature on health expendi-
ture per capita has speciﬁed three main sources of determinants: (i) income; (ii) demographic
factors describing the population age structure; and (iii) other exogenous factors such as rate
of inﬂation, the nature of the health care system, stock of health care structure (such as
manpower, hospital beds, etc) and non-medical health determinants of the population.
13 In
the regression of this paper, we also include these three categories. Income variable is described
as GDP (y).
14 For demographics, we did not use young or old population ratios as most of the
literature has done.
15 Instead, crude mortality rate, urban population ratio, population density
and population growth are used to describe a country’s general demographic information. The
exogenous factors that are included in our estimate regression are threefold:
D: nature of the health care system—public sector provision,
16 insurance coverage
E: Environmental variables—water pollution,
17 location (in Asia or not)
Z: the stock of health care structure—health employment, bed number
Since the main purpose of this paper is to project the steady state optimal investment
amount, our regression equation needs further inclusion of the growth variables so that the
Golden Rule status of investment amount can be estimated at the snapshot when these growth
rates approach zero. As a result, the growth rate of GDP and the growth rate of health
expenditure are included to capture a nation’s dynamic transition. None of the previous
12 McDonald and Roberts (2002), for example, ﬁnd that the results for OECD countries have the coe$cients
0.173, 0.067, and -.225 for investment, education, and (ngd) respectively. The coe$cients for health variables
in the two studies are di#erent, though. McDonald and Roberts use life expectancy as their health indicator, which
has been criticized by Knowles and Owen (1995) as crude. One possible approach is to proxy health capital by the
proportion of income spent on health inputs. Thus we use the ratio of health expenditure to GDP instead.
13 For more detailed information, please see Hitiris and Posnett (1992).
14 GDP adjusted by purchasing power parity (PPP) is used in this paper to reﬂect a constant consumer price in
di#erent countries.
15 According to Getzen (1992), rising health expenditure and rising ages are the result of an indirect relation-
ship with other variables. Also Moise and Jacobzone (2003) indicate there is little correlation between per capita
health expenditure and percentage of population aged over 65.
16 Share of total health expenditure that is covered under public programs.
17 percentage points of total BOD emissions and organic water pollutant emissions level, kg per day.
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idea of this paper will add to the existing literature some novelty and robustness in the
health-expenditure related ﬁeld.
To estimate the optimal health expenditure for each country at di#erent time periods, the
regression equation is estimated by a panel ﬁxed-e#ect Tobit model to account for the positive
nature of health expenditure:
HEi,tf(HEGi,t,d y i,t,y i,t,h i,t,k i,t,D i,t,E i,t,Z i,t),
where HEit denotes health expenditure per e#ective unit of labor for the ith country in
year t as the proxy for gross health stock investment, HEG denotes the per e#ective unit of
labor growth rate of health care expenditure, y denotes GDP per capita, dy denotes the growth
rate of GDP, and D, E, Z denotes the above-mentioned exogenous variables. Since this is panel
data, the time and country dummy variables are used to ﬁx the time and country-speciﬁc
e#ects. The data include 15
18 OECD countries with a time frame of 19 years. However,
missing data are sporadic; the number of available observations left for regression is only 202.
19
To obtain the steady-state health expenditure amount, the two-stage least square method
20
is employed treating the growth rate of health expenditure as endogenous since this is the
variable we primarily focus on when inducing the steady state value and it is determined by
many other social, political, and environmental factors. By deﬁnition, the steady-state level
occurs when the growth rate of the variable approaches zero. Thus, it can be obtained by
substituting the steady-state output level for the output level and suppressing the growth rate
of per e#ective unit of labor health expenditure and growth rate of GDP, thus setting them in
e#ect equal to zero.
To ensure the robustness of the empirical results, two types of health expenditure
measures are employed as the dependent variables: the ratio of health expenditure to GDP and
the real health expenditure per e#ective unit of labor in logarithms, measured at purchasing
power parity (PPP) level, with regression results presented in the ﬁrst and second columns,
respectively, of Table 1. Both results have quite consistent signs for each of the explanatory
variables. The negative sign of the mortality rate suggests that if the society considers health
a less important issue they would then spend less money on it, which would result in a less
hygienic environment and hence a higher mortality rate. The negative sign for the unemploy-
ment rate implies that a society with a lower employment level would devote less money to
health and the government also would have less money for public health expenditure. The
more densely populated countries and the countries with higher population growth also cannot
a#ord much health expense. On the other hand, the countries with higher health capital such
as hospital beds and health personnel require higher health expenditure. That signals either
that such countries value healthcare more highly or that the countries spend larger amounts of
money to maintain the human health and physical capital stocks.
18 The selection of these 15 countries is based on the availability of data.
19 For data after 1980, each country still has di#erent lengths of available data for all variables. However, this
does not a#ect the result of our analysis since the missing data is sporadic. When using interpolate and extrapolate
methods to test the data set, similar results are generated. Hence, only the results from the original data set are
reported. For this reason, we hope that the concerns about missing data problem can be minimized, if not totally
eliminated.
20 The method of panel Tobit is applied since the health expenditure level is left-censored to be larger than zero.
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equations at the 1% signiﬁcance level. This result supports our theoretical prediction from
equation 8. Speciﬁcally, for a one percent increase in the growth rate of GDP, the share of
health expenditure in GDP decreases by 0.31 percent, ceteris paribus, from the ﬁrst regression,
and decreases by 0.04 percent for per e#ective unit of labor health expenditure from the second
regression (the dependent variable is in natural logarithmic form). As mentioned earlier, the
richer countries tend to have a lower rate of GDP growth than the poorer but they value
healthcare and quality of life more heavily so that their optimal health expenditures are larger.
As a result, the negative relationship is expected.
The coe$cient of GDP, however, has a negative sign in the regression of share of GDP.
This seems to contradict the previous argument and the previous literature. Usually richer
countries tend to have lower growth rate and higher health expenditure. But when the growth
variables are held constant, higher GDP level implies fewer resources in percentage of GDP
that can be devoted to health expenditure, indicating that health expenditure as a share of
GDP converges as GDP increases and, hence, societies adjust toward optimal amounts for
investment as economies grow. This e#ect is signiﬁcant in the regression of the share of Health
Expenditure in GDP—a one percent increase in GDP causes the share of HE in GDP to
decrease 6.79 percent, holding all other variables constant. The coe$cients for health policies
also exhibit expected results. A higher ratio of people covered by health insurance encourages
T67A: 1. R:<G:HH>DC R:HJAIH
Variables Share of GDP HE Per Capita
Mortality Rate 0.044(1.04) 0.009(1.85)**
Urban Pop. 0.112(1.19) 0.011(0.98)
Unemployment rate 0.068(2.82)*** 0.012(4.45)***
Pop. Growth 0.002(0.71) 0.001(2.23)***
Pop. Density 2.626(6.10)*** 0.242(6.66)***
Bed number 2.650(4.61)*** 0.450(7.04)***
Physical Capital 0.096(0.41) 0.033(1.23)





Public HE Share 1.199(3.11)*** 0.211(4.66)***
Public HE Share
2 8.125(2.72)*** 1.534(4.36)***
Water pollution 0.186(1.90)** 0.050(4.85)***
Org. Water Pollution 0.000(7.12)*** 0.000(6.88)***
Growth rate of GDP 0.312(5.94)*** 0.042(6.81)***
Asia 1.406(1.33) 0.167(1.32)
Growth rate of HE 0.442(4.88)*** 0.060(5.80)***
ProbF 0.000 0.000
Wald Chi
2 (48) 2988.17 27915.10
Log Likelihood 67.59 370.11
Observation 202 202
Note: a. GDP, Bed Number, Health Employment are in logarithms. All else are in percentage. Asia is a
dummy variable indicating countries located in Asia.
b. The t-statistics are in parentheses.
c. *, **, and *** denote 10%, 5%, and 1% level of signiﬁcance, respectively.
[June =>IDIHJ76H=> ?DJGC6A D; :8DCDB>8H +*the nation’s health expenditure. But a larger share for public health expenditure results in
smaller total national health expenditure in both regression results. The plausible explanation
is that a country has better control over health spending through a centralized system. The
F><.1 . R :A6I>DCH=>E 7:IL::nR :6A HE E:G E;;:8I>K: UC>I D; L67DG 6C9
PGD?:8I:9 SI:69N SI6I: V6AJ:
F><.2 . R :A6I>DCH=>E 7:IL::C I=: A8IJ6A FG68I>DC D; HE >C GDP 6C9
PGD?:8I:9 V6AJ:
Note: Thin line — actual value
Bold line — projected value
2006] :8DCDB>8 <GDLI=, =JB6C 86E>I6A >CK:HIB:CI, 6C9 =:6AI= :ME:C9>IJG: ++environmental variables also play signiﬁcant roles in both of the regressions. The negative signs
may be explained by the same reason as the negative sign of the mortality rate.
The main idea for this paper is to understand the trend of health expenditures for the
OECD countries and to compare them to the steady-state optimal amount of health expendi-
tures for each country. In order to do so, the projected optimal steady-state expenditure
amount is imputed for each country at possible time periods. The results are shown in Figures
1 and 2. The former presents the actual real health expenditure per e#ective unit of labor
measured at PPP basis with comparison to its estimated optimal value and the latter one
presents the health expenditure as share of GDP also compared to the estimated optimal share.
The bold line represents the estimated value and the thin line is the actual value. Both ﬁgures
present consistent results. Almost all countries exhibit a higher level of actual health expendi-
ture than the projected value, meaning that overspending in health expenditure is generally
present. Looking closely at the graphs, we observe that for some countries these two lines move
closer over time and ﬁnally overlap together such as for Canada, Denmark, Finland, Israel,
Italy, Japan, Norway, and Sweden. This shrinkage in the gaps implies that those countries have
carried out the health expenditure containment process successfully. Even though both the
thin line and the bold line in both ﬁgures for the above countries show increasing trends over
time, the projected optimal steady state value increases at a faster rate than the actual
expenditure level. For some other countries such as France, Netherlands, the UK and the US,
the amount of overspending is also decreasing but the healthcare expenditure has not yet
reached the optimal amount. Thus, for these countries, further control of health expenditure
is needed. For the rest of the countries, Spain and Greece, there is no sign of shrinkage in the
gaps, meaning that in the past two decades, health consumption is consistently over- spent. In
particular, health expenditure per e#ective unit of labor has been overspent by an average 34%
and 46% for Spain and Greece, respectively, in the past two decades. If measured by the share
of health expenditure in GDP, the average actual shares are 4.97% and 6.19% for Spain and
Greece, respectively. But their corresponding optimal rates are only 0.52% and 2.00%. These
data strongly suggest that both countries re-evaluate their health policy and ﬁnd more
stringent cost containment methods. Interestingly, the insured rates in these two countries
increased dramatically in the 1980s to about 100 percent of the late 1980s while the public
sharing rate for Greece has stayed constant and decreased for Spain (please refer to Figure 3).
If government is more e$cient in controlling spending, then these two countries may consider
vesting more control in the central system. Another traditional way of cost containment is to
increase the co-payment amount for patients.
21 Both approaches might be considered by
relevant health authorities when reviewing their health policies for future reform plans.
V. Conclusion
This study applies economic growth theory to explain the long-term increasing nature of
healthcare expenditure in a growing economy. Health consumption can be considered as an
investment in human capital since it improves labor’s working ability by promoting worker
reliability, energy and attention. Since healthcare has been treated as a “luxury good” in many
21 Some price control methods are also introduced by Barros and Xavier (2002).
[June =>IDIHJ76H=> ?DJGC6A D; :8DCDB>8H +,studies, it is plausible to assume that investment in health is subject to a diminishing marginal
return and that convergence between rich and poor countries is present. A theoretical model
following the Solow growth model is developed in this paper to explain the convergence and
the increasing nature of the investment in either physical or human capital. The traditional
thinking of merely looking at the expenditure or investment amount and deciding which is
soaring beyond control is arbitrary. On the other hand, the optimal investment amount has to
be determined by considering the whole economy’s growth situation.
The empirical analysis employs 15 countries from OECD to compare the actual health
expenditure and the theoretically projected Golden Rule steady-state expense level. The results
of the regression analyses are consistent with conventional predictions. The comparison
between the actual and projected values indicates the presence of overspending for most of the
countries. Some countries show signs of success in cost containment from the shrinkage
between the actual and the projected optimal amount over time. Others appear to have
unapparent cost containment plans such as Spain and Greece. It is hoped that this study can
provide guidance for the government authorities in planning health policies relative to
healthcare expenditure.
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